Search
for

    Sort by

    Research 30 of 1000+

    1. Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation Aesthetic Surgery Journal · 2023 · 25 citations
    2. First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS Oncology Times · 2009
    3. Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq” Journal of cancer research updates · 2026
    4. Aesthetic medicine treatments for oncology patients — a narrative literature review Nowotwory Journal of Oncology · 2026
    5. Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients Nutrients · 2025
    6. Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy Pharmaceuticals · 2025
    7. Farmácia Serpa Pinto, Porto e Serviços Farmacêuticos do Instituto Português Oncologia do Porto Francisco Gentil, EPE, Porto Open Repository of the University of Porto (University of Porto) · 2024
    8. Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database Frontiers in Oncology · 2026
    9. Advancements in Therapeutic Deep Eutectic Solvents as Multifunctional Transdermal Delivery Systems Pharmaceutics · 2026
    10. Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature European Journal of Dermatology · 2023
    11. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients Clinical & Translational Oncology · 2024 · 5 citations
    12. Hormonal manipulation of benign prostatic hyperplasia Current opinion in urology · 2012 · 18 citations
    13. Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges Pharmaceutics · 2025
    14. Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas Neuro-Oncology · 2025 · 1 citations
    15. Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer Oncology Reviews · 2026
    16. ODAC Votes No on IntraDose Injectible Cisplatin/Epinephrine Gel for Head and Neck Cancer Oncology Times · 2001
    17. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®) European journal of oncology nursing · 2004 · 35 citations
    18. Arsenic Trioxide as Effective Therapy for Relapsed Acute Promyelocytic Leukemia Clinical journal of oncology nursing · 2002 · 22 citations
    19. Provenge is Talk of GU Malignancies Congress Oncology Times · 2010
    20. Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications Pharmaceuticals · 2026
    21. Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions MedComm · 2025 · 9 citations
    22. Repurposed Drugs: Current Trends in Drug Discovery IntechOpen eBooks · 2024
    23. Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials JAAD reviews. · 2025
    24. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications IntechOpen eBooks · 2020 · 39 citations
    25. Transmasculine Hormone Therapy Endocrinology and Metabolism Clinics of North America · 2019 · 6 citations
    26. Antibody Drug Conjugates Oncology Times · 2020
    27. Skin cancer risk in alopecia areata: a systematic review and meta-analysis Frontiers in Oncology · 2026
    28. Safety of High-Dose Vitamin A Oncology · 2009 · 39 citations
    29. Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany Therapeutic Advances in Medical Oncology · 2023 · 34 citations
    30. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations